Ranked by engagement
Top topics — this year page 4
Ranked by replies, likes and views over this year, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,076 topics · page 4 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Can a home kit substitute for a laboratory report? A careful no
Asking directly, because I could not find a straight answer: Can a home kit substitute for a laboratory report? A careful no I would like to disagree carefully with the settled view on home kit substitute,…
|
+122 | 131 | 1.7k | 5mo |
|
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
|
+124 | 133 | 11k | 5mo |
|
Personal import allowances, compared — a second dataset
Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Personal import allowances. It is mine, it is…
|
+124 | 132 | 9.2k | 2mo |
|
Journal club: is percentage weight change the right endpoint?
Journal club: is percentage weight change the right endpoint? I have a specific reason for asking rather than idle curiosity, and the context is below. Bringing a claim rather than a paper, because the claim…
|
+116 | 120 | 23k | 3mo |
|
Pinch or no pinch, and how needle length changes the answer
Pinch or no pinch, and how needle length changes the answer Writing it up because I had to work it out twice and would rather nobody else did. A question about pinch that I think has a definite answer, unlike…
|
+118 | 126 | 11k | 9mo |
|
Reference intervals: how they are constructed and why one in twenty flags
Reference intervals: how they are constructed and why one in twenty flags — setting out what I have, and where I think it stops being reliable. Reference intervals: what I expected, what I found, and the gap…
|
+104 | 119 | 30k | 1mo |
|
What is genuinely unknown about long-term amylin agonism
What is genuinely unknown about long-term amylin agonism — that is the question, and I have not found it answered plainly anywhere I have looked. A comparison question rather than a question about one…
|
+83 | 91 | 46k | 1d |
|
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are fragile
On the subject in the title: Second pass at: Adsorptive losses at low concentration, and why dilute solutions are fragile Working notes rather than a conclusion. The question about Adsorptive losses that I…
|
+77 | 87 | 58k | 4mo |
|
Spreadsheets: an appreciation — what changed since
Spreadsheets: an appreciation — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Spreadsheets is wrong? I ask because I have…
|
+102 | 113 | 26k | 17h |
|
Reading a trial's population section before its results
On the subject in the title: Reading a trial's population section before its results Working notes rather than a conclusion. Reading STEP 2 ( Lancet , 2021) for the population rather than the effect, which I…
|
+91 | 109 | 22k | 2mo |
|
Submitting a sample: the process end to end
On the subject in the title: Submitting a sample: the process end to end Working notes rather than a conclusion. Submitting a sample keeps being re-asked here and I think that is because the answer is…
|
+99 | 114 | 29k | 21h |
|
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Posting a small dataset on ABAB design. It is mine, it is…
|
+106 | 118 | 25k | 4mo |
|
The "under review" status pill and when a moderator applies it
Posting this under the heading it deserves: The "under review" status pill and when a moderator applies it Everything below is what sits behind that. A question about how this site should cite something that…
|
+96 | 119 | 17k | 3mo |
|
Coming back to: An 18-month record including the parts that went badly
Posting this under the heading it deserves: An 18-month record including the parts that went badly Everything below is what sits behind that. Asking about 18-month record on behalf of the question I keep…
|
+83 | 89 | 52k | 12mo |
|
Stepping down deliberately, and how to do it without losing progress
Stepping down deliberately, and how to do it without losing progress — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how…
|
+98 | 102 | 26k | 3mo |
|
I joined for one answer and stayed for a year — what changed my mind
Posting this under the heading it deserves: I joined for one answer and stayed for a year — what changed my mind Everything below is what sits behind that. Question in the title and the context underneath, in…
|
+95 | 114 | 17k | just now |
|
Official shortage notices and what they authorise
Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Trying to work out what would count as evidence on official shortage…
|
+106 | 119 | 18k | 1mo |
|
Trust level 3 requirements: a clarification — does this still hold?
Asking directly, because I could not find a straight answer: Trust level 3 requirements: a clarification — does this still hold? Two things I would like separated before anyone answers on Trust level 3…
|
+77 | 90 | 57k | 9h |
|
Research-use-only labelling: what it means and what it does not
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. A labelling question, and I would like the answer to be…
|
+100 | 110 | 37k | 5mo |
|
Reverse causation in a cohort study of weight and outcome — a second dataset
Reverse causation in a cohort study of weight and outcome — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Reverse causation. It…
|
+112 | 131 | 1.5k | 10mo |
|
Half-life, steady state, and accumulation worked through — a second dataset
Half-life, steady state, and accumulation worked through — a second dataset — setting out what I have, and where I think it stops being reliable. Working through the kinetics rather than the pharmacology,…
|
+110 | 126 | 14k | 4mo |
|
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just differently reported?
Tirzepatide and nausea: is the profile genuinely different or just differently reported? I have a specific reason for asking rather than idle curiosity, and the context is below. Something about Tirzepatide…
|
+109 | 122 | 3.6k | 2mo |
|
[2026 update] Cardiovascular risk: reading the outcome trials as a set
Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. I have spent a fortnight trying to pin Cardiovascular risk down…
|
+99 | 103 | 32k | 11mo |
|
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I think the…
|
+104 | 110 | 16k | 2d |
|
Pooling trials with different estimands
On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion. Asking about pooling trials with different estimands on behalf of the question I keep seeing asked…
|
+120 | 132 | 2.3k | 1d |
|
BPC-157: what the rodent literature actually shows, and what it does not — a second dataset
On the subject in the title: BPC-157: what the rodent literature actually shows, and what it does not — a second dataset Working notes rather than a conclusion. The question about BPC-157 that I actually want…
|
+77 | 84 | 54k | 11mo |
|
Forced degradation studies: designing one that is informative
Posting this under the heading it deserves: Forced degradation studies: designing one that is informative Everything below is what sits behind that. Collecting what is known about forced degradation studies…
|
+100 | 106 | 35k | 2d |
|
Payment method and the leverage it gives you, ranked
Posting this under the heading it deserves: Payment method and the leverage it gives you, ranked Everything below is what sits behind that. A payments question, with the mechanics separated from the money.…
|
+71 | 76 | 56k | 10mo |
|
Anaesthesia and elective surgery: the aspiration question
Posting this under the heading it deserves: Anaesthesia and elective surgery: the aspiration question Everything below is what sits behind that. A narrow question about anaesthesia and elective surgery,…
|
+103 | 115 | 6.6k | 3mo |
|
A ten-fold dose error caught before injection
A ten-fold dose error caught before injection — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on ten-fold dose error caught, before…
|
+95 | 103 | 26k | 10mo |